Mount Sinai South Nassau — Oceanside, New York

Mount Sinai South Nassau is a clinical research site located in Oceanside, New York, United States 11572.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai South Nassau has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Gestational Diabetes Mellitus (GDM), SARS-CoV2 Infection, Endoscopic Retrograde Cholangiopancreatography (ERCP).

Sponsors: Icahn School of Medicine at Mount Sinai, Gilead Sciences, Ambu A/S.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai South Nassau?

Mount Sinai South Nassau has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai South Nassau conducted?

Mount Sinai South Nassau has 3 clinical trials on record, with 1 currently active. Their work covers Gestational Diabetes Mellitus (GDM), SARS-CoV2 Infection, Endoscopic Retrograde Cholangiopancreatography (ERCP).

Is Mount Sinai South Nassau accredited by Crixeo Health?

Mount Sinai South Nassau has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai South Nassau?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.